ArticleJournal of the American College of Cardiology2016
Vena Caval Filter Utilization and Outcomes in Pulmonary Embolism: Medicare Hospitalizations From 1999 to 2010.
Article in Journal of the American College of Cardiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Systematic review of efficacy and safety of retrievable inferior vena caval filters.Thrombosis research · 2018Pooled it
- Inferior Vena Cava Filters to Prevent Pulmonary Embolism: Systematic Review and Meta-Analysis.Journal of the American College of Cardiology · 2017Pooled it
- Trends and Predictors of Vena Cava Filter Use (2004-2023): A Swiss Nationwide Epidemiological Study.TH open : companion journal to thrombosis and haemostasis · 2025Article
- The Role of IVC Filters in the Management of Acute Pulmonary Embolism.Journal of clinical medicine · 2024Review
- Incidence and risk factors for inferior vena cava filter thrombosis detected at time of filter retrieval in patients with lower extremity deep vein thrombosis: a multicenter retrospective cohort study.Quantitative imaging in medicine and surgery · 2023Article
- A review of inferior vena cava filters.The British journal of radiology · 2023Review
- Back to the Basics: Inferior Vena Cava Filters.Seminars in interventional radiology · 2022Review
- Association of Socioeconomic Disadvantage With Mortality and Readmissions Among Older Adults Hospitalized for Pulmonary Embolism in the United States.Journal of the American Heart Association · 2021Article
- Structured team-oriented program to follow patients after vena cava filter placement: a step forward in improving quality for filter retrieval.Scientific reports · 2021Article
- Use and Removal of Inferior Vena Cava Filters in Patients With Acute Brain Injury.The Neurohospitalist · 2020Article
- New guidelines for the diagnosis and management of pulmonary embolism: Key changes.World journal of cardiology · 2020Article
- Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism.Internal and emergency medicine · 2019Article
- Association of Inferior Vena Cava Filter Use With Mortality Rates in Older Adults With Acute Pulmonary Embolism.JAMA internal medicine · 2019Article
- Association of Inferior Vena Cava Filter Placement for Venous Thromboembolic Disease and a Contraindication to Anticoagulation With 30-Day Mortality.JAMA network open · 2018Article
- Association of Admission Glucose Level and Improvement in Pulmonary Artery Pressure in Patients with Submassive-type Acute Pulmonary Embolism.Internal medicine (Tokyo, Japan) · 2018Observational
- Article
- Inferior vena cava filter use and patient safety: legacy or science?Hematology. American Society of Hematology. Education Program · 2017Review
- Trends in Perioperative Venous Thromboembolism Associated with Major Noncardiac Surgery.TH open : companion journal to thrombosis and haemostasis · 2017Article
- Successful Management of Intraoperative Acute Bilateral Pulmonary Embolism in a High Grade Astrocytoma Patient.The American journal of case reports · 2016Article
Corrections and comments
- Commented on by
Authors and funding
11 authors.
Funding
Abstract
backgroundInferior vena caval filters (IVCFs) may prevent recurrent pulmonary embolism (PE). Despite uncertainty about their net benefit, patterns of use and outcomes of these devices in contemporary practice are unknown.
objectivesThe authors determined the trends in utilization rates and outcomes of IVCF placement in patients with PE and explored regional variations in use in the United States.
methodsIn a national cohort study of all Medicare fee-for-service beneficiaries ≥65 years of age with principal discharge diagnoses of PE between 1999 and 2010, rates of IVCF placement per 100,000 beneficiary-years and per 1,000 patients with PE were determined. The 30-day and 1-year mortality rates after IVCF placement were also investigated.
resultsAmong 556,658 patients hospitalized with PE, 94,427 underwent IVCF placement. Between 1999 and 2010, the number of PE hospitalizations with IVCF placement increased from 5,003 to 8,928, representing an increase in the rate per 100,000 beneficiary-years from 19.0 to 32.5 (p < 0.001 for both). As the total number of PE hospitalizations increased (from 31,746 in 1999 to 54,392 in 2010), the rate of IVCF placement per 1,000 PE hospitalizations did not change significantly (from 157.6 to 164.1, p = 0.11). Results were consistent across demographic subgroups, although IVCF use was higher in blacks and patients ≥85 years of age. IVCF utilization varied widely across regions, with the highest rate in the South Atlantic region and the lowest rate in the Mountain region.
conclusionsIn a period of increasing PE hospitalizations among Medicare fee-for-service beneficiaries, IVCF placement increased as utilization rates in patients with PE remained greater than 15%. Mortality associated with PE hospitalizations is declining, regardless of IVCF use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.